• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Serum lipid and glucose profiles in HIV-positive Nigerian children.尼日利亚HIV阳性儿童的血脂和血糖情况
J Virus Erad. 2017 Jul 1;3(3):157-162. doi: 10.1016/S2055-6640(20)30335-6.
2
Serum lipids and glucose abnormalities in HIV/AIDS patients on antiretroviral therapies.接受抗逆转录病毒治疗的艾滋病毒/艾滋病患者的血脂和血糖异常
West Afr J Med. 2009 Jan;28(1):10-5. doi: 10.4314/wajm.v28i1.48417.
3
Prevalence and correlates of traditional risk factors for cardiovascular disease in a Nigerian ART-naive HIV population: a cross-sectional study.尼日利亚未接受抗逆转录病毒治疗的HIV人群中心血管疾病传统危险因素的患病率及其相关因素:一项横断面研究。
BMJ Open. 2018 Jul 19;8(7):e019664. doi: 10.1136/bmjopen-2017-019664.
4
Insulin resistance and lipid profiles in HIV-infected Thai children receiving lopinavir/ritonavir-based highly active antiretroviral therapy.接受基于洛匹那韦/利托那韦的高效抗逆转录病毒疗法的泰国感染艾滋病毒儿童的胰岛素抵抗和血脂情况
J Pediatr Endocrinol Metab. 2014 May;27(5-6):403-12. doi: 10.1515/jpem-2013-0253.
5
Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial.布基纳法索和科特迪瓦艾滋病毒感染儿童在基于洛匹那韦增强型利托那韦的早期治疗成功后基于依非韦伦的简化治疗:MONOD ANRS 12206非劣效性随机试验
BMC Med. 2017 Apr 24;15(1):85. doi: 10.1186/s12916-017-0842-4.
6
Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate.接受抗逆转录病毒药物治疗的HIV疾病患者的脂质代谢紊乱:发生率、与所用药物的关系以及苯扎贝特降脂治疗的作用
J Infect. 2001 Apr;42(3):181-8. doi: 10.1053/jinf.2001.0829.
7
Hyperlipidaemia in HIV-infected patients on lopinavir/ritonavir monotherapy in resource-limited settings.资源有限环境下接受洛匹那韦/利托那韦单一疗法的HIV感染患者的高脂血症
Antivir Ther. 2017;22(3):205-213. doi: 10.3851/IMP3101. Epub 2016 Oct 14.
8
Impact of switching from lopinavir/ritonavir to boosted and un-boosted atazanavir on glucose metabolism: the ATAzanavir & GLUcose metabolism (ATAGLU) study.从洛匹那韦/利托那韦转换为增强和非增强型阿扎那韦对糖代谢的影响:阿扎那韦与糖代谢(ATAGLU)研究
Int J STD AIDS. 2016 Jul;27(8):638-43. doi: 10.1177/0956462415590724. Epub 2015 Jun 10.
9
An open-label, randomized study of the impact on insulin sensitivity, lipid profile and vascular inflammation by treatment with lopinavir/ritonavir or raltegravir in HIV-negative male volunteers.一项关于洛匹那韦/利托那韦或拉替拉韦治疗对HIV阴性男性志愿者胰岛素敏感性、血脂谱和血管炎症影响的开放标签随机研究。
Antivir Ther. 2017;22(2):145-151. doi: 10.3851/IMP3098. Epub 2016 Oct 6.
10
Significant improvement in triglyceride levels after switching from ritonavir to cobicistat in suppressed HIV-1-infected subjects with dyslipidaemia.在血脂异常的 HIV-1 感染受抑制的受试者中,从利托那韦转换为考比司他后,甘油三酯水平显著改善。
HIV Med. 2017 Nov;18(10):782-786. doi: 10.1111/hiv.12530. Epub 2017 Jul 3.

引用本文的文献

1
Cardiometabolic Health Burden in Pediatric HIV: Unmet Need in the Contemporary Antiretroviral Therapy Era.儿科HIV患者的心脏代谢健康负担:当代抗逆转录病毒治疗时代未满足的需求
Cureus. 2025 Jun 4;17(6):e85329. doi: 10.7759/cureus.85329. eCollection 2025 Jun.
2
Dietary patterns and metabolic morbidities correlate among adolescents and young adults with HIV in Lagos, Nigeria: A cross-sectional study design.尼日利亚拉各斯青少年和青年艾滋病毒感染者的饮食模式与代谢疾病之间的相关性:一项横断面研究设计。
J Multimorb Comorb. 2025 May 11;15:26335565251341388. doi: 10.1177/26335565251341388. eCollection 2025 Jan-Dec.
3
Correlates of fasting blood glucose among children living with hiv in a Nigerian tertiary hospital: a cross-sectional study.尼日利亚一家三级医院中感染艾滋病毒儿童的空腹血糖相关因素:一项横断面研究。
BMC Pediatr. 2020 Oct 2;20(1):458. doi: 10.1186/s12887-020-02335-y.

本文引用的文献

1
Effectiveness and safety of generic version of abacavir/lamivudine and efavirenz in treatment naïve HIV-infected patients: a nonrandomized, open-label, phase IV study in Cali-Colombia, 2011-2012.阿巴卡韦/拉米夫定和依非韦伦仿制药在初治HIV感染患者中的有效性和安全性:2011 - 2012年在哥伦比亚卡利进行的一项非随机、开放标签的IV期研究。
BMC Infect Dis. 2016 Oct 3;16(1):532. doi: 10.1186/s12879-016-1871-x.
2
Household Fuel Use and Cardiovascular Disease Mortality: Golestan Cohort Study.家庭燃料使用与心血管疾病死亡率:戈勒斯坦队列研究
Circulation. 2016 Jun 14;133(24):2360-9. doi: 10.1161/CIRCULATIONAHA.115.020288.
3
Longitudinal analysis of the associations between antiretroviral therapy, viraemia and immunosuppression with lipid levels: the D:A:D study.抗逆转录病毒疗法、病毒血症、免疫抑制与血脂水平之间关联的纵向分析:D:A:D研究
Antivir Ther. 2016;21(6):495-506. doi: 10.3851/IMP3051. Epub 2016 Apr 26.
4
Progress Toward HIV Eradication: Case Reports, Current Efforts, and the Challenges Associated with Cure.迈向 HIV 根除的进展:病例报告、当前努力和与治愈相关的挑战。
Annu Rev Med. 2016;67:215-28. doi: 10.1146/annurev-med-011514-023043. Epub 2015 Nov 2.
5
Dyslipidemia in HIV Infected Children Receiving Highly Active Antiretroviral Therapy.接受高效抗逆转录病毒治疗的HIV感染儿童的血脂异常
Indian J Pediatr. 2016 Mar;83(3):226-31. doi: 10.1007/s12098-015-1859-3. Epub 2015 Sep 3.
6
Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs.抗逆转录病毒疗法对人类免疫缺陷病毒感染患者脂质代谢的影响:新旧药物
World J Virol. 2015 May 12;4(2):56-77. doi: 10.5501/wjv.v4.i2.56.
7
Lipid and glucose alterations in perinatally-acquired HIV-infected adolescents and young adults.围生期感染 HIV 的青少年和青年中脂类和糖代谢的改变。
BMC Infect Dis. 2015 Mar 8;15:119. doi: 10.1186/s12879-015-0853-8.
8
Managing dyslipidemia in HIV/AIDS patients: challenges and solutions.管理艾滋病毒/艾滋病患者的血脂异常:挑战与解决方案。
HIV AIDS (Auckl). 2014 Dec 17;7:1-10. doi: 10.2147/HIV.S46028. eCollection 2015.
9
Improved serum cholesterol in paediatric patients switched from suppressive lopinavir-based therapy to boosted darunavir or atazanavir: an 18-month retrospective study.从基于洛匹那韦的抑制性疗法转换为增强型达芦那韦或阿扎那韦治疗的儿科患者血清胆固醇改善情况:一项18个月的回顾性研究
HIV Med. 2014 Nov;15(10):635-6. doi: 10.1111/hiv.12180.
10
Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy.初治抗反转录病毒治疗 3 年后 HIV 感染非洲儿童脂代谢障碍和代谢异常的流行率。
Pediatr Infect Dis J. 2015 Feb;34(2):e23-31. doi: 10.1097/INF.0000000000000491.

尼日利亚HIV阳性儿童的血脂和血糖情况

Serum lipid and glucose profiles in HIV-positive Nigerian children.

作者信息

Ige Olukemi O, Yilgwan Christopher S, Ebonyi Augustine O, Adah Ruth, Adedeji Idris, Yiltok Esther S, Oguche Stephen, Bode-Thomas Fidelia

机构信息

Department of Paediatrics, University of Jos, Nigeria.

Department of Paediatrics, Jos University Teaching Hospital, Nigeria.

出版信息

J Virus Erad. 2017 Jul 1;3(3):157-162. doi: 10.1016/S2055-6640(20)30335-6.

DOI:10.1016/S2055-6640(20)30335-6
PMID:28758024
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5518245/
Abstract

OBJECTIVES

To describe the fasting serum lipid and glucose profiles of HIV-positive Nigerian children and determine the prevalence and risk factors for dyslipidaemia and hyperglycaemia, which are risk factors for cardiovascular diseases.

METHODS

This was a comparative cross-sectional study carried out at the Paediatric Infectious Disease Clinic (PIDC) of the Jos University Teaching Hospital (JUTH) for HIV-positive children and at two primary schools in Jos for HIV-negative children as controls. One hundred and forty-two HIV-positive children aged 6-18 years and an equal number of controls were studied by determining their fasting serum lipid and glucose levels. The prevalence of dyslipidaemia and hyperglycaemia was determined and their risk factors obtained using multivariate logistic regression. values of less than 0.05 were considered statistically significant.

RESULTS

Mean triglyceride levels were significantly higher in HIV-positive children compared with controls at 87.2 mg/dL (95% confidence interval [CI] 79.4-95.0) and 68.1 mg/dL (95% CI 62.5-72.7), respectively (<0.001). There were no significant differences in mean glucose levels. Dyslipidaemia was significantly higher in HIV-positive children (21.8%) compared with controls (12.7%; 0.04). Total serum cholesterol was elevated in 17 (12.0%) HIV-positive participants compared with seven (4.9%) of controls (0.02). Children on lopinavir/ritonavir (LPV/r) and those with no significant or mild disease had a significantly higher prevalence of hypercholesterolaemia (33.3% 4.8% and 14.5% 0.0%, respectively; <0.001).

CONCLUSION

HIV-positive children on antiretroviral (ARV) drugs, especially LPV/r, should have their lipids regularly monitored as those with dyslipidaemia stand the risk of subsequently developing cardiovascular diseases.

摘要

目的

描述尼日利亚HIV阳性儿童的空腹血脂和血糖情况,并确定血脂异常和高血糖的患病率及危险因素,这些都是心血管疾病的危险因素。

方法

这是一项比较性横断面研究,在乔斯大学教学医院(JUTH)的儿科传染病诊所(PIDC)对HIV阳性儿童进行研究,并在乔斯的两所小学选取HIV阴性儿童作为对照。通过测定142名6至18岁的HIV阳性儿童及同等数量对照儿童的空腹血脂和血糖水平进行研究。确定血脂异常和高血糖的患病率,并使用多因素逻辑回归分析其危险因素。P值小于0.05被认为具有统计学意义。

结果

HIV阳性儿童的平均甘油三酯水平显著高于对照组,分别为87.2mg/dL(95%置信区间[CI]79.4 - 95.0)和68.1mg/dL(95%CI 62.5 - 72.7)(P<0.001)。平均血糖水平无显著差异。HIV阳性儿童的血脂异常率(21.8%)显著高于对照组(12.7%;P = 0.04)。与对照组的7名(4.9%)相比,17名(12.0%)HIV阳性参与者的总血清胆固醇升高(P = 0.02)。接受洛匹那韦/利托那韦(LPV/r)治疗的儿童以及无明显疾病或轻度疾病的儿童高胆固醇血症患病率显著更高(分别为33.3%对4.8%和14.5%对0.0%;P<0.001)。

结论

接受抗逆转录病毒(ARV)药物治疗的HIV阳性儿童,尤其是接受LPV/r治疗的儿童,应定期监测血脂,因为血脂异常者有随后发生心血管疾病的风险。